Common questions about Sitorel (FAQ)
Q: What is the main condition Sitorel is approved to treat?
Sitorel is officially indicated for the treatment of opioid-induced constipation (OIC) in two specific populations. These are adults with chronic non-cancer pain and adults with advanced illness receiving palliative care.
Q: Is Sitorel a generic or a brand-name medication?
The substance within Sitorel, methylnaltrexone bromide, is the active component of a brand-name medication. Official regulatory documents list the active ingredient, and the drug may also be known by its brand name.
Q: What class of medicine does Sitorel belong to?
Sitorel belongs to a class of medicines known as peripherally acting mu-opioid antagonists. The class is described as working by blocking the effect of opioids in specific areas of the body without significant penetration into the central nervous system.
Q: How long does it typically take to notice the expected effects of Sitorel?
Official clinical study data indicate a relatively rapid onset of effect for the injection formulation. In these studies, most patients who responded had a bowel movement within four hours of receiving the injection, with a median time of 24 minutes.
Q: How does Sitorel affect your liver or kidney function?
Official prescribing information notes that Sitorel is processed by the body in ways that involve the liver and kidneys. For this reason, official guidance states that a dosage adjustment is required for adult patients diagnosed with moderate or severe renal impairment (kidney issues) or severe hepatic impairment (liver issues). Dose adjustments are required for patients with these specific conditions.
Q: Are there any known long-term side effects of taking Sitorel for an extended period?
Regulatory documentation indicates that research is limited on the effects of Sitorel beyond a few months. Specifically, the use of the injection formulation for periods longer than four months has not been studied in the population of patients with advanced illness. The evidence remains insufficient regarding the long-term patterns and sustained safety of this medication.
Q: Is Sitorel safe to use if I am also taking supplements or herbal products?
Official drug information indicates that certain herbal products can potentially alter the amount of Sitorel in the body. For example, some products, like St. John's Wort, are known to reduce drug levels, which could decrease the medicine's effectiveness. Official guidance restricts the co-administration of the drug with certain herbal products.
Q: Is Sitorel appropriate for use by elderly patients?
Official prescribing information notes that special caution is warranted when Sitorel is used by older adults (specifically those over 75 years). This is due to a documented increased risk of neurological and vascular-related effects, including a higher risk of falls.
Q: Is it generally okay to take Sitorel at night instead of in the morning?
The official product information specifies that the oral tablet formulation is specified to be taken once daily in the morning on an empty stomach. This timing is part of the administration requirements described in regulatory documents.
Q: What are the results of the long-term safety studies on Sitorel?
Research evidence summaries indicate that current data is limited regarding long-term outcomes and sustained use of Sitorel. The official limitations of use note that use beyond four months has not been studied in certain patient populations. Further research is noted as needed to provide clearer insight into long-term safety patterns.
Q: Why do some people report that Sitorel did not work for them?
Research evidence summaries indicate that clinical trial results for the drug have shown mixed findings across some studies, and the quality of evidence has varied. These variations in research results may contribute to differences in how individual patients experience the medicine's effects.
Q: How is Sitorel eliminated from the body?
Sitorel is extensively broken down, or metabolized, by enzymes in the liver. After metabolism occurs, official sources indicate that the majority of the substance is excreted from the body via the urine, largely in its unchanged form.
Q: Does Sitorel have a risk of dependence or withdrawal symptoms if stopped?
Regulatory safety documents describe that opioid withdrawal symptoms have been reported in rare postmarketing instances. These reported symptoms include signs such as anxiety, sweating, chills, and muscle aches.
Q: Can you take Sitorel with alcohol?
Official drug interaction information notes that there is one alcohol/food interaction identified for the substance. This means that consuming alcohol may alter the way the drug works in the body.
Q: Does Sitorel interact with common over-the-counter pain relievers?
Official regulatory data indicates the substance may interact with several common over-the-counter pain relievers, such as acetaminophen or ibuprofen. These interactions could potentially lead to a higher level of Sitorel in the bloodstream.
Q: Can Sitorel be used by children or teenagers?
Official prescribing information addresses the use of Sitorel in younger patients. The guidance states that the use and appropriate dosage of the medicine in children are determined by a healthcare provider.
Q: Is it safe to take Sitorel during pregnancy?
According to official documents, safety has not been established, and data are inadequate regarding use in human pregnancy. Furthermore, its use may precipitate opioid withdrawal in the developing fetus.
Q: Can people who are breastfeeding use Sitorel?
It is currently unknown if the substance is excreted into human milk. Official guidance describes that avoiding breastfeeding is recommended while using the drug.
Q: Does Sitorel need to be stored in the refrigerator?
Official storage guidelines indicate that the medicine's tablet form is recommended to be kept in a closed container at room temperature. It is described as being stored away from heat, moisture, and direct light to maintain its stability.
Q: What happens if Sitorel gets exposed to high temperatures or humidity?
Regulatory storage guidance emphasizes that the medicine is described as being stored away from both high heat and excessive moisture. Exposure to these conditions may affect the drug's quality and stability.
Q: What is the recommended method for disposing of expired or unused Sitorel?
Official guidance describes that patients may ask a healthcare professional or pharmacist for the correct disposal method. Alternatively, patients may follow the FDA's guidance for disposing of 'Non-Flush List' medicines in household trash.
Q: How long after stopping Sitorel does the substance typically stay in the body's system?
Official documents describe the elimination rate of the substance from the body. The elimination half-life is approximately 7 to 12 hours, meaning this is the time it takes for the concentration of the drug to decrease by half.
Q: What does 'bioavailability' mean when referring to Sitorel?
Bioavailability is a term used to describe the fraction of the substance that enters the bloodstream after administration. Official regulatory information states that the oral formulation of Sitorel has a very low bioavailability, measured as less than 5%.
Q: What is the purpose of the different strengths Sitorel is available in?
Regulatory documents explain that different strengths and dose calculations are available for the drug. This is done to allow for dosing adjustments based on patient weight and for patients with conditions such as renal impairment.
Q: Does Sitorel cause any changes in mood or emotional state?
Regulatory safety documents indicate that some emotional changes have been reported in rare postmarketing instances. Specifically, symptoms associated with opioid withdrawal, such as anxiety or nervousness, have been observed.
